2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS]
TED · 485103-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 14 | — | 2026-07-07 |
| GILEAD SCIENCES, LDA | 12 | — | 2026-07-14 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 11 | €1,569,649 | 2026-07-14 |
| NOVARTIS FARMA - PROD.FARM SA | 9 | — | 2026-06-30 |
| AMGEN BIOFARMACEUTICA, LDA | 8 | €396,644 | 2026-06-24 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-14 | 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-02 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-07-07 | 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |